Clinical significance of myocardial work parameters after acute myocardial infarction.

Global work efficiency Myocardial infarction Myocardial work

Journal

European heart journal open
ISSN: 2752-4191
Titre abrégé: Eur Heart J Open
Pays: England
ID NLM: 9918282081406676

Informations de publication

Date de publication:
May 2022
Historique:
received: 25 04 2022
accepted: 10 05 2022
entrez: 3 8 2022
pubmed: 4 8 2022
medline: 4 8 2022
Statut: epublish

Résumé

To investigate the additional prognostic value of myocardial work (MW) parameters following acute myocardial infarction (AMI). Between 2018 and 2020, 244 patients admitted in the cardiac intensive care unit in Lille University Hospital for AMI were included. One-month following AMI, comprehensive transthoracic echocardiography (TTE) was performed to assess parameters of myocardial function. Patients were then followed for major events (ME): cardiovascular death, heart failure, and unplanned coronary revascularization. At 1-month, half of the population was symptomatic (NYHA ≥ II), and medical therapy was almost optimized (angiotensin-converting enzyme inhibitor/angiotensin 2 receptor blocker in 95.5%, beta-blockers in 96.3%, DAPT in 94.7%, and statins in 97.1%). After a median follow-up of 681 (interquartile range: 538-840) days, ME occurred in 26 patients (10.7%). Patients presenting ME were older (65.5 ± 14.2 vs. 58.1 ± 12.1years, Lower GWE at 1 month after AMI is independently associated with higher ME rates. A GWE <91% can improve the post-AMI patient risk stratification.

Identifiants

pubmed: 35919347
doi: 10.1093/ehjopen/oeac037
pii: oeac037
pmc: PMC9242079
doi:

Types de publication

Journal Article

Langues

eng

Pagination

oeac037

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Eur Heart J Cardiovasc Imaging. 2018 Sep 1;19(9):1010-1018
pubmed: 28954293
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Am J Cardiol. 2005 Aug 1;96(3):325-31
pubmed: 16054451
Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1372-1379
pubmed: 29529181
J Am Soc Echocardiogr. 2020 Oct;33(10):1180-1190
pubmed: 33010853
Coron Artery Dis. 2017 Dec;28(8):636-641
pubmed: 28914638
Eur Heart J Cardiovasc Imaging. 2015 Nov;16(11):1247-55
pubmed: 25851329
Eur Heart J Cardiovasc Imaging. 2021 Feb 22;22(3):259-261
pubmed: 33257982
J Am Soc Echocardiogr. 2019 Jan;32(1):1-64
pubmed: 30282592
Eur Heart J. 2012 Mar;33(6):724-33
pubmed: 22315346
J Am Soc Echocardiogr. 2012 Jun;25(6):644-51
pubmed: 22406163
J Am Soc Echocardiogr. 2019 Aug;32(8):947-957
pubmed: 31043359
J Am Soc Echocardiogr. 2015 Feb;28(2):183-93
pubmed: 25623220
Circulation. 2018 Nov 13;138(20):e618-e651
pubmed: 30571511
Am J Cardiol. 2017 Jan 1;119(1):27-34
pubmed: 27788932
Circulation. 2014 Aug 26;130(9):743-8
pubmed: 25074505
JACC Cardiovasc Imaging. 2019 Dec;12(12):2549-2554
pubmed: 31326486
Circ Cardiovasc Imaging. 2009 Sep;2(5):356-64
pubmed: 19808623
Circ Cardiovasc Imaging. 2021 Mar;14(3):e012072
pubmed: 33653082
Int J Cardiol. 2014 Nov 15;177(1):281-6
pubmed: 25499393
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
J Am Soc Echocardiogr. 2013 Feb;26(2):185-91
pubmed: 23218891
J Am Soc Echocardiogr. 2010 Oct;23(10):1019-24
pubmed: 20810243

Auteurs

Augustin Coisne (A)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Victor Fourdinier (V)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Gilles Lemesle (G)

Heart and Lung Institute, University Hospital of Lille, F-59000 Lille, France.

Pascal Delsart (P)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Samy Aghezzaf (S)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Nicolas Lamblin (N)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur, U1167, F-59000 Lille, France.

Guillaume Schurtz (G)

Heart and Lung Institute, University Hospital of Lille, F-59000 Lille, France.

Basile Verdier (B)

Heart and Lung Institute, University Hospital of Lille, F-59000 Lille, France.

Sandro Ninni (S)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Antoine Delobelle (A)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Francesco Favata (F)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Camille Garret (C)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Claire Seunes (C)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Amandine Coppin (A)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Erwan Donal (E)

University of Rennes, CHU Rennes, Inserm, LTSI - UMR 1099, F-35000 Rennes, France.

Andrea Scotti (A)

Cardiovascular Research Foundation, New York, NY, USA.

Azeem Latib (A)

Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

Juan F Granada (JF)

Cardiovascular Research Foundation, New York, NY, USA.

Christophe Bauters (C)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur, U1167, F-59000 Lille, France.

David Montaigne (D)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1011- EGID, F-59000 Lille, France.

Classifications MeSH